Long Term Follow-up of Human Hydatid Disease (Echinococcus granulosus) Treated with a High-Dose Mebendazole Regimen

William S. Kammerer Department of Medicine, The Milton S. Hershey Medical Center of the Pennsylvania State University, Parasitic Disease Division, Centers for Disease Control, Hershey, Pennsylvania 17033

Search for other papers by William S. Kammerer in
Current site
Google Scholar
PubMed
Close
and
Peter M. Schantz Department of Medicine, The Milton S. Hershey Medical Center of the Pennsylvania State University, Parasitic Disease Division, Centers for Disease Control, Hershey, Pennsylvania 17033

Search for other papers by Peter M. Schantz in
Current site
Google Scholar
PubMed
Close
Restricted access

Fifteen patients with inoperable hydatid disease (Echinococcus granulosus) were treated with an initial 6-week high-dose mebendazole regimen with a follow-up ranging from 3–7 years. Ten of 15 patients showed both objective and clinical improvement, although two of these 10 relapsed 1–6 years after completing therapy. Simple, single cysts in the lung and liver showed the best response. Multiple, complex cysts and bone cysts showed little or no objective improvement. One patient developed reversible neutropenia. Overall results were no better than those obtained by others with smaller doses.

Author Notes

 

 

 

 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save